CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-23). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1227 · Search date 2026-07-23 · Methodology v0.6

Spanish black radish extract,
does it really help with Improved acetaminophen metabolism and toxin elimination by activating hepatic detoxification enzymes?

30-Second Summary
D
Evidence Grade D · 25 · Safety unknown
Metabolite changes were observed, but clinical toxin elimination and liver protection remain unproven
What the
research shows
Spanish black radish is rated D because its human evidence consists of one manufacturer-sponsored, open-label, single-arm study. Twenty healthy men took the product for four weeks and showed changes in acetaminophen metabolites, but there was no placebo group, enzyme activity was not directly measured, and no clinical detoxification or liver-injury outcome improved.
What the
ads claim
Marketing turns a shift in metabolite proportions into claims that toxins leave the body faster and the liver is protected. The study did not measure removal of common environmental toxins, symptoms, or liver-disease outcomes.
*

Useful facts when choosing a product

  • Spanish black radish is a glucosinolate-containing cruciferous root sold as dried powder or tablets.
  • The product in the open human study also contained small amounts of acerola, honey, and tapioca ingredients, so it was not identical to a purified extract.
  • No serious adverse event occurred in the four-week study and one case of indigestion was considered possibly related, but safety data are limited for crucifer allergy and gallbladder or bowel-obstruction disorders.
Gap Measurement · Verdict 1227 · D 25
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Evans 2014 gave a product for four weeks to 20 healthy men and compared acetaminophen metabolites after a 1,000-mg challenge before and after supplementation. Nineteen completed the study; selected plasma metabolite areas under the curve fell and urinary patterns changed, but the study was open label, single arm, and sponsored by Standard Process. Hanlon 2007 found induction of selected phase I and II enzyme expression in a human hepatoma cell line, which is not a human efficacy trial.

02

Why this is classified as D (25)

The evidence is manufacturer-sponsored, open label, uncontrolled, limited to 20 participants, and based on surrogate metabolites without clinical toxin-removal or liver-protection outcomes, yielding D with 25 points.

Counterpoint. Acetaminophen overdose is not a situation for a supplement; it requires immediate toxicology assessment and standard antidotal care.

Rejudgment record. Cross-check applied — Applied D because the only human evidence is a manufacturer-sponsored open single-arm study of 20 men reporting acetaminophen metabolite changes without a control group, direct enzyme-activity measurement, or clinical toxin-removal or liver-protection outcome

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Activation of hepatic detoxification enzymesDThe human study inferred induction from metabolites and hormones rather than directly measuring enzyme activity.
Improved acetaminophen metabolismDUncontrolled pre-post metabolite changes do not establish causality or clinical benefit.
Improved toxin eliminationDNo human trial measured removal of general toxins or a health outcome.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Evans M, Paterson E, Barnes DM. 2014Single-center open-label single-arm pre-post pilot19Sponsored by product manufacturer Standard ProcessPlasma and urinary metabolites and hormones after a 1,000-mg acetaminophen challengeSelected metabolite concentrations and excretion patterns changed, but there was no placebo group and no clinical toxin-removal or liver-protection outcome.Only direct human evidence with very low reliability
Hanlon PR, Webber DM, Barnes DM. 2007Experiment in the human HepG2 hepatoma cell lineProduct-related basic researchExpression and activity of phase I and II detoxification enzymesAqueous black-radish extract induced selected enzyme expression.Mechanistic evidence only, not human efficacy
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-23).

Evans M, Paterson E, Barnes DM. An open label pilot study to evaluate the efficacy of Spanish black radish on the induction of phase I and phase II enzymes in healthy male subjects. BMC Complement Altern Med. 2014;14:475. PMID: 25490898. DOI: 10.1186/1472-6882-14-475.
checked
Hanlon PR, Webber DM, Barnes DM. Aqueous extract from Spanish black radish (Raphanus sativus L. Var. niger) induces detoxification enzymes in the HepG2 human hepatoma cell line. J Agric Food Chem. 2007;55(16):6439-6446. DOI: 10.1021/jf070530f.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-23 · Corrections: none

Cite this verdict

Spanish black radish extract x improved acetaminophen metabolism and toxin elimination Evidence Grade D card
[Chamgap] Spanish black radish extract x improved acetaminophen metabolism and toxin elimination — Evidence Grade D·25. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/liver/spanish-black-radish-liver-detox-acetaminophen/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.